• Best Practices New Normal
  • Digital Dentistry
  • Data Security
  • Implants
  • Catapult Education
  • COVID-19
  • Digital Imaging
  • Laser Dentistry
  • Restorative Dentistry
  • Cosmetic Dentistry
  • Periodontics
  • Oral Care
  • Evaluating Dental Materials
  • Cement and Adhesives
  • Equipment & Supplies
  • Ergonomics
  • Products
  • Dentures
  • Infection Control
  • Orthodontics
  • Technology
  • Techniques
  • Materials
  • Emerging Research
  • Pediatric Dentistry
  • Endodontics
  • Oral-Systemic Health

ADA Scientific Panel: Patients at elevated risk for developing cavities benefit from applying topical fluoride

Publication
Article
dentalproductsreport.comdentalproductsreport.com-2013-10-01
Issue 10

Patients at elevated risk for developing cavities benefit from applying prescription fluoride directly to their teeth at home or having their dentist apply it in the office, according to new clinical recommendations from a multi-disciplinary expert panel convened by the American Dental Association (ADA) Council on Scientific Affairs.

Patients at elevated risk for developing cavities benefit from applying prescription fluoride directly to their teeth at home or having their dentist apply it in the office, according to new clinical recommendations from a multi-disciplinary expert panel convened by the American Dental Association (ADA) Council on Scientific Affairs.

Topical fluoride, used in conjunction with drinking optimally fluoridated water and using toothpaste with fluoride, is helpful to prevent tooth decay in these particular patients.

The summary of these updated clinical recommendations, "Topical Fluoride for Caries Prevention: Executive Summary of the Updated Clinical Recommendations and Supporting Systematic Review,” is published in the November issue of The Journal of the American Dental Association (JADA) and will be available to the public Nov. 1 on the ADA’s Center for Evidence-Based Dentistry (EBD) website and ADA members on the JADA website.

These clinical recommendations cover professionally applied and prescription-strength, home-use topical fluoride agents for cavity prevention.

This marks the first time that these evidence-based recommendations were updated based on a systematic review of clinical studies. The authors reviewed clinical studies on fluoride mouth rinses, varnishes, gels, foams and pastes.

Evidence-based clinical recommendations are intended to provide dentists and other health professionals with a review of the latest scientific evidence on particular topics and are not considered a standard of care. Rather, health care professionals can consider clinical recommendations, patient preference and their own clinical judgment when diagnosing and treating patients.

The panel concluded that additional research is needed, but recommended the following for patients at elevated risk of developing cavities:

  • Professionally-applied 2.26 percent fluoride varnish or a 1.23 percent fluoride gel every 3-6 months

  • Home-use prescription-strength 0.5 percent fluoride gel or paste or 0.09 percent fluoride mouth rinse (for patients 6 years old or older)

  • A 2.26 percent professionally-applied fluoride varnish every 3-6 months is recommended for children younger than 6 years old

Additionally, the recommendations specify the fluoride concentrations that provide the best benefit and indicate that APF foam not be used in children younger than 6 years old due to the potential of swallowing the foam. 

Foam is also not recommended for children older than 6 years old and adults due to a lack of evidence for benefit. In addition, the panel recommended that clinicians determine a patient’s risk for developing cavities by conducting a caries risk assessment. 

The ADA recommends the following oral hygiene habits to fight tooth decay:  brushing twice a day with fluoride toothpaste, flossing daily, eating a balanced diet and visiting your dentist regularly for checkups.

The full report of the clinical recommendations, a chairside guide for dentists to use to talk to their patients and an audio podcast summary of the recommendations will be available Nov. 1 on the EBD website.

 

Related Videos
2024 Dental Products Report Spring Selection Bracket Reveal Video
Process of Care Workflow and Repairing Early Caries with Guided Enamel Remineralization
Addressing Unmet Needs in Early Childhood Oral Care - an interview with Ashlet Lerman, DDS
Mastermind Episode 33 – Charting the Course for the Future of Dentistry
CDS 2024 Midwinter Meeting – Interview with Debbie Zafiropoulos, who discusses a trio of new infection control products from Armis Biopharma.
2024 Chicago Dental Society Midwinter Meeting – Interview with Peter Maroon, business development and sales lead at Spectrum Solutions® on the new salivary diagnostic test, SimplyPERIO.
CDS 2024: Ivoclar's e.max ZirCAD Prime Blocks with Shashi Singhal, BDS, MS
CDS 2024: Diving Deep on J. Morita's New Root ZX3 & HF Module
CDS 2024: What's New at TAG University? with Andrew De la Rosa, DMD
Related Content
© 2024 MJH Life Sciences

All rights reserved.